GlassScriptPhysician profile
Usman Saleem
NPI 1225203367
$1,177.31
in general payments reported to CMS, 2019-2025
13 companies · $790 in 2025
The $790 reported for 2025 was more than what 93% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $54.61 · 2023: $14.74 · 2024: $318 · 2025: $790.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,122.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $499.09 | 2025 | Senza |
| Abbvie INC. | $123.95 | 2025 | |
| Djo, LLC | $121.43 | 2024 | Cmf |
| Biocomposites INC | $120.00 | 2024 | |
| Valinor Pharma, LLC | $80.68 | 2025 | Movantik |
| Saluda Medical Americas, INC. | $54.78 | 2025 | Evoke |
| Nevro Corp. | $34.73 | 2022 | |
| Biotronik Nro, INC. | $31.86 | 2025 | Prospera |
| Forte Bio-Pharma LLC | $31.45 | 2024 | Prolate, Nalocet |
| Gebauer Company | $23.87 | 2024 | |
| Zimmer Biomet Holdings, INC. | $20.85 | 2024 | Gel-One Cross-Linked Hyaluronate |
| Horizon Therapeutics Plc | $19.88 | 2022 | |
| Metacel Pharmaceuticals LLC | $14.74 | 2023 | Ozobax |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Usman Saleem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.